Targeted Expression of a Protease-resistant IGFBP-4 Mutant in Smooth Muscle of Transgenic Mice Results in IGFBP-4 Stabilization and Smooth Muscle Hypotrophy

This publication has 57 references indexed in Scilit:

• Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes
  New England Journal of Medicine, 2001
• Distribution of Chimeric IGF Binding Protein (IGFBP)-3 and IGFBP-4 in the Rat Heart: Importance of C-Terminal Basic Region
  Endocrinology, 2001
• Systemic Administration of Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Increases Bone Formation Parameters in Mice by Increasing IGF Bioavailability via an IGFBP-4 Protease-Dependent Mechanism
  Endocrinology, 2001
• The Complement Component C1s Is the Protease That Accounts for Cleavage of Insulin-like Growth Factor-binding Protein-5 in Fibroblast Medium
  Journal of Biological Chemistry, 2000
• Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice.
  Journal of Clinical Investigation, 1997
• Genetic ablation of IGFBP-2 suggests functional redundancy in the IGFBP family
  Progress in Growth Factor Research, 1995
• Insulin-like growth factor I and its binding proteins in the cardiovascular system
  Cardiovascular Research, 1995
• Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta.
  Hypertension, 1994
• Insulin-like growth factor binding protein (IGFBP)4 accounts for the connective tissue distribution of endothelial cell IGFBPs perfused through the isolated heart
  Endocrinology, 1992
• Actions of insulin-like growth factor-I on the B104 neuronal cell line: Effects on cell replication, receptor characteristics, and influence of secreted binding protein on ligand binding
  Journal of Cellular Physiology, 1989